Eczema Free Forever™

Dermira Commits $135M for Global Rights to Roche Eczema Drug – Xconomy


Xconomy
Dermira Commits $ 135M for Global Rights to Roche Eczema Drug
Xconomy
Skin treatments developer Dermira is adding another experimental drug to its pipeline that it plans to test as a potential treatment for eczema, through a deal announced this morning with healthcare giant Roche. But in picking up the global rights to …
Dermira Enters into Agreement to License Exclusive, Worldwide Rights to LebrikizumabGlobeNewswire (press release)

all 9 news articles »

eczema – Google News

Eczema Free Forever™